Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 10,091 | 0 | 406 | 0 |
| Gross Profit | N/A | 10,091 | 0 | 406 | N/A |
| Operating Expenses | 58,929 | 48,848 | 53,271 | 43,311 | 44,377 |
| Operating Income | -58,929 | -38,757 | -53,271 | -42,905 | -44,377 |
| Interest Expense | 10,174 | 19,269 | 30,128 | 5,014 | 5,020 |
| Other Income | 10,882 | 5,328 | 6,204 | 2,049 | 3,885 |
| Pre-tax Income | -58,221 | -52,698 | -77,195 | -45,870 | -45,512 |
| Income Tax | 51 | -8 | -24 | -21 | 40 |
| Net Income Continuous | -58,272 | -52,690 | -77,171 | -45,849 | -45,552 |
| Net Income | $-58,272 | $-52,690 | $-77,171 | $-45,849 | $-45,552 |
| EPS Basic Total Ops | -0.22 | -0.24 | -0.45 | -0.26 | -0.26 |
| EPS Basic Continuous Ops | -0.22 | -0.24 | -0.44 | -0.26 | -0.26 |
| EPS Diluted Total Ops | -0.22 | -0.24 | -0.45 | -0.26 | -0.26 |
| EPS Diluted Continuous Ops | -0.22 | -0.24 | -0.44 | -0.26 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.24 | -0.44 | N/A | N/A |
| EBITDA(a) | $-57,034 | $-36,951 | $-51,496 | $-41,526 | $-42,865 |